Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Amortization of Deferred Charges (2016 - 2020)

Historic Amortization of Deferred Charges for STRATA Skin Sciences (SSKN) over the last 8 years, with Q2 2020 value amounting to -$79000.0.

  • STRATA Skin Sciences' Amortization of Deferred Charges fell 11944.44% to -$79000.0 in Q2 2020 from the same period last year, while for Sep 2020 it was $254000.0, marking a year-over-year increase of 179333.33%. This contributed to the annual value of $318000.0 for FY2019, which is N/A changed from last year.
  • Per STRATA Skin Sciences' latest filing, its Amortization of Deferred Charges stood at -$79000.0 for Q2 2020, which was down 11944.44% from $79000.0 recorded in Q1 2020.
  • Over the past 5 years, STRATA Skin Sciences' Amortization of Deferred Charges peaked at $254000.0 during Q4 2019, and registered a low of -$79000.0 during Q4 2018.
  • For the 5-year period, STRATA Skin Sciences' Amortization of Deferred Charges averaged around $39222.2, with its median value being $45500.0 (2016).
  • Per our database at Business Quant, STRATA Skin Sciences' Amortization of Deferred Charges plummeted by 56470.59% in 2018 and then surged by 42151.9% in 2019.
  • STRATA Skin Sciences' Amortization of Deferred Charges (Quarter) stood at $55000.0 in 2016, then crashed by 69.09% to $17000.0 in 2017, then tumbled by 564.71% to -$79000.0 in 2018, then soared by 421.52% to $254000.0 in 2019, then crashed by 131.1% to -$79000.0 in 2020.
  • Its Amortization of Deferred Charges stands at -$79000.0 for Q2 2020, versus $79000.0 for Q1 2020 and $254000.0 for Q4 2019.